Clinical Trials Insight: 700044859
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2009
At a glance
- Drugs EP 42675 (Primary)
- Indications Acute coronary syndromes; Thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Endotis Pharma
- 16 Jul 2009 Results reported at the 22nd Congress of the International Society on Thrombosis and Haemostasis.
- 26 May 2009 New trial record.